Intelligence · Drug directory

Pipeline & Investigational Drugs

Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.

Quick answer

Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.

1,610 drugs · Pipeline · by data quality · Page 3 of 68

  1. colestilan

    BINDREN

    EMA: withdrawn

    V03AE
  2. copanlisib

    ALIQOPA

    EMA: application withdrawn

  3. copper (64cu) oxodotreotide

    DEQTYNET

    EMA: unknown

    V09IX15
  4. covid-19 vaccine (ad26.cov2-s [recombinant])

    JCOVDEN (PREVIOUSLY COVID-19 VACCINE JANSSEN)

    EMA: withdrawn

    J07BN02
  5. covid-19 vaccine (chadox1-s [recombinant])

    VAXZEVRIA (PREVIOUSLY COVID-19 VACCINE ASTRAZENECA)

    EMA: withdrawn

    J07BN02
  6. covid-19 vaccine (inactivated, adjuvanted, adsorbed)

    COVID-19 VACCINE (INACTIVATED, ADJUVANTED) VALNEVA

    EMA: withdrawn

    J07BX03
  7. crizanlizumab

    ADAKVEO

    EMA: unknown

    B06AX01
  8. daclatasvir

    DAKLINZA

    EMA: unknown

    J05AP07
  9. dasabuvir

    EXVIERA

    EMA: withdrawn

    J05AP09
  10. dasiprotimut-t

    LYMPREVA

    EMA: refused

    L03AX
  11. delandistrogene moxeparvovec

    ELEVIDYS

    EMA: refused

    M09AX15
  12. depreotide

    NEOSPECT

    EMA: withdrawn

    V09IA05
  13. desirudin

    REVASC

    EMA: withdrawn

    B01AE01
  14. dexamethasone phosphate

    DEXAMETHASONE TAW

    EMA: application withdrawn

    H02AB02
  15. diclofenamide

    EKESIVY

    EMA: application withdrawn

    S01EC02
  16. diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) vaccine (adsorbed)

    INFANRIX PENTA

    EMA: unknown

    J07CA12
  17. diphtheria (d), tetanus (t), pertussis (whole cell) (pw) and hepatitis b (rdna) (hbv) vaccine (adsorbed)

    TRITANRIX HEPB

    EMA: unknown

    J07CA05
  18. diphtheria, tetanus and hepatitis b (rdna) vaccine (adsorbed)

    PRIMAVAX

    EMA: withdrawn

    J07CA
  19. diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed)

    TRIACELLUVAX

    EMA: withdrawn

    J07AJ
  20. diphtheria, tetanus, acellular pertussis and hepatitis b recombinant, adsorbed vaccine

    INFANRIX HEPB

    EMA: withdrawn

    J07CA
  21. diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis b (recombinant) and haemophilus influenzae type b conjugate vaccine, adjuvanted

    HEXAVAC

    EMA: withdrawn

    J07CA
  22. diphtheria, tetanus, pertussis (whole cell), hepatitis b (rdna) and haemophilus influenzae type b conjugate vaccine (absorbed)

    QUINTANRIX

    EMA: withdrawn

    J07CA10
  23. dodecafluoropentane

    ECHOGEN

    EMA: withdrawn

    V08DA
  24. drotrecogin alfa (activated)

    XIGRIS

    EMA: withdrawn

    B01AD10

Frequently asked questions

How many pipeline drugs are listed?

1,610 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.